Connect with us

Health

NIH-Moderna Investigational COVID-19 Vaccine Shows Promise – SciTechDaily

Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing. The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published …

Published

on

post featured image

Colorized scanning electron micrograph of a VERO E6 cell (blue) heavily infected with SARS-COV-2 virus particles (orange), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing.
The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COV…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Can a prior rhinovirus infection protect against COVID-19? – News-Medical.Net
Article feature image
When could double vaccinated people face fewer COVID restrictions? – Yahoo News Australia